Abbey Miller
Family · Hutchinson, KSNPI 1215739826
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,359 of the $1,642 with a category attached, or 82.8%. It is spread thinly across 30 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations.
Across 70 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$274
- AbbVie$161
- Exelixis Inc.$148
- Johnson & Johnson$143
- Novartis$103
- Pfizer$88
- plus $726 from 24 others
What the payments were for
- Food & beverage$1,35983%
- Education$28317%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $274 |
| AbbVie | 7 | $161 |
| Exelixis Inc. | 3 | $148 |
| Johnson & Johnson | 9 | $143 |
| Novartis | 5 | $103 |
| Pfizer | 4 | $88 |
| Incyte Corporation | 4 | $77 |
| Merck | 3 | $68 |
| Spectrum Pharmaceuticals Inc. | 3 | $54 |
| Sanofi | 2 | $53 |
| Tersera Therapeutics LLC | 2 | $48 |
| GSK | 2 | $39 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Array Biopharma Inc | 2 | $37 |
| Sobi, Inc | 1 | $26 |
| EMD Serono, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
| Recordati_rare_diseases_inc. | 1 | $24 |
| Genmab U.S., Inc. | 1 | $24 |
| Rigel Pharmaceuticals, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Caris MPI, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Stemline Therapeutics Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Bristol Myers Squibb | 1 | $14 |
| Iovance Biotherapeutics, Inc. | 1 | $7 |
How this compares
$1,642 in reported general payments places this provider in the 80th percentile of 1,579 family providers in Kansas.
Other family in Hutchinson
- Zohra HussainiKansas City$329K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Tatum TolandTopeka$108K
- Mary GonzalesWichita$87K
- Erin FeitzOverland Park$36K
- Adam CaseKansas City$34K
- Jaimie HeldstabWestwood$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.